Medicine and Dentistry
Immunohistochemistry
70%
Programmed Death-Ligand 1
70%
Monoclonal Antibody
70%
Non Small Cell Lung Cancer
70%
Therapeutic Procedure
70%
Antibody
70%
Diagnosis
64%
Tumor Cell
52%
Patient
46%
Neoplasm
46%
Laboratory
35%
Hodgkin's Lymphoma
35%
Immunotherapy
23%
Examination
23%
Pathology
23%
Diagnostic Pathology
23%
Pembrolizumab
23%
Oncology
23%
False Negative Result
17%
Kidney Tissue
17%
Lymphoma
17%
Assessment
17%
Epitope
17%
Specimen
17%
Tissues
17%
Nursing and Health Professions
Quality Control
100%
Molecular Weight
70%
Cytokeratin 8
70%
Laboratory
60%
Immunohistochemistry
29%
Patient
29%
Clinical Outcome
9%
Food and Drug Administration
9%
Quality Adjusted Life Year
9%
Earth and Planetary Sciences
Socioeconomic Impact
70%
Growth
70%
Cost
40%
Economics
29%
Quality Control
29%
United States
20%
Estimate
20%
Health Care
20%
Survival
20%
Model
20%
Economic Data
9%
Country
9%
Low Cost
9%
Accuracy
9%